Medindia

X

ADHD Drugs Should Have All The Warnings On The Label

by Medindia Content Team on  February 14, 2006 at 6:33 PM Drug News   - G J E 4
ADHD Drugs Should Have All The Warnings On The Label
Attention deficit hyperactivity disorder (ADHD) is characterized by failure to have continuous attention, restlessness, is also associated with poor performance in school, conduct problems and drug abuse.
Advertisement

Ritalin and other stimulants are prescribed to treat this disease. But drug experts say that these drugs prescribed for attention deficit hyperactivity disorder (ADHD) should carry the most serious type of warning labels.

Advertisement
The Food and Drug Administration (FDA) committee insisted that the drugs should carry safety warnings. These warnings are especially for the physicians and patients telling them about the significant risks the particular drug can potentially induce.

Statistics show that about 51 deaths have occurred among children and adults who are taking these drugs for ADHD in the US since 1999. It is also associated with high blood pressure, chest pain, heart attacks, strokes, irregular heartbeats and fainting.

Dr. Peter Gross, the panel chairman and head of internal medicine at Hackensack University Medical Center in New Jersey said that the side effect such as sudden death should be made clear to the physicians.

The disease is commonly diagnosed is in children, especially boys, physicians have recently started writing more prescriptions for adults. Each month about 1 million prescriptions are written for ADHD drugs for adults and about 2 million for children.

Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All